Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Verastem (VSTM) EBIT: 2018-2025

Historic EBIT for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to -$40.7 million.

  • Verastem's EBIT fell 9.95% to -$40.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$160.2 million, marking a year-over-year decrease of 53.09%. This contributed to the annual value of -$115.0 million for FY2024, which is 24.84% down from last year.
  • According to the latest figures from Q3 2025, Verastem's EBIT is -$40.7 million, which was up 6.97% from -$43.8 million recorded in Q2 2025.
  • Over the past 5 years, Verastem's EBIT peaked at -$14.1 million during Q1 2021, and registered a low of -$44.2 million during Q1 2025.
  • Its 3-year average for EBIT is -$30.5 million, with a median of -$29.8 million in 2024.
  • Data for Verastem's EBIT shows a peak YoY increase of 46.48% (in 2021) and a maximum YoY decrease of 198.86% (in 2021) over the last 5 years.
  • Over the past 5 years, Verastem's EBIT (Quarterly) stood at -$16.5 million in 2021, then decreased by 2.03% to -$16.8 million in 2022, then declined by 20.33% to -$21.3 million in 2023, then tumbled by 73.78% to -$31.6 million in 2024, then decreased by 9.95% to -$40.7 million in 2025.
  • Its last three reported values are -$40.7 million in Q3 2025, -$43.8 million for Q2 2025, and -$44.2 million during Q1 2025.